Spinal cord injury often triggers a cascade of secondary damage that severely limits functional recovery, largely driven by ...
Cancer immunotherapies often rely on activating immune responses, yet many tumors remain resistant because their internal survival mechanisms are ...
Cancer immunotherapies often rely on activating immune responses, yet many tumors remain resistant because their internal survival mechanisms are poorly understood.
Namodenoson (CF102), an investigational small-molecule A3 adenosine receptor (A3AR) agonist, has demonstrated favorable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results